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Supernumerary centrosomes promote the assembly
of abnormal spindles in many human cancers. The
observation that modest changes in the centrosomal
levels of Mps1 kinase can cause centrosome over-
duplication in human cells suggests the existence of
a regulatory system thatmay tightly control its centro-
somal stability. Here, we show that Cdkn3, a Cdk-
associated phosphatase, prevents Mps1-mediated
centrosome overduplication. We identify Cdkn3 as a
direct binding partner of Mps1. The interaction be-
tweenMps1 andCdkn3 is required for Mps1 to recruit
Cdkn3 to centrosomes. Subsequently, Mps1-bound
Cdkn3 forms a regulatory system that controls the
centrosomal levels of Mps1 through proteasome-
mediated degradation and thereby prevents Mps1-
mediated centrosome overduplication. Conversely,
knockdownofCdkn3stabilizesMps1atcentrosomes,
which promotes centrosome overduplication. We
suggest that Mps1 and Cdkn3 form a self-regulated
feedback loop at centrosomes to tightly control the
centrosomal levels of Mps1, which prevents centro-
some overduplication in human cells.
INTRODUCTION
During the cell cycle, a single centrosome must be duplicated
only once during S phase to generate the two centrosomes
necessary to form a proper bipolar spindle. A causal association
between centrosome overduplication and human cancer devel-
opment has long been hypothesized (Boveri, 2008). Indeed,
supernumerary centrosomes are frequently detected in human
cancers, and centrosome abnormalities are considered a com-
mon feature of all major classes of human cancers (Godinho
and Pellman, 2014).
Mps1 (monopolar spindle 1), first identified in the yeast
S. cerevisiae (Winey et al., 1991), is an evolutionary conserved
dual-specificity kinase that plays multiple roles during the cell
cycle (Liu and Winey, 2012). Phenotypic analysis of the original
yeast Mps1 mutants identified key functions of the Mps1 kinase
in spindle pole body (SPB) duplication (Winey et al., 1991) andCell Repthe spindle assembly checkpoint (SAC) (Weiss and Winey,
1996). Mps1 also regulates multiple steps during the SPB dupli-
cation process (Araki et al., 2010; Elserafy et al., 2014; Holinger
et al., 2009; Schutz and Winey, 1998).
In mammalian cells, Mps1 has beenmost widely studied for its
involvement in establishing bipolar spindle attachment and SAC
at the kinetochores (Funabiki and Wynne, 2013; Liu and Winey,
2012). However, a requirement for Mps1 in centrosome duplica-
tion has been controversial, particularly in human cells depleted
of Mps1 (Fisk et al., 2003; Pike and Fisk, 2011; Stucke et al.,
2002). In contrast to a lack of Mps1, excess Mps1 levels at
centrosomes influence centrosome duplication in mouse and
human cells (Fisk et al., 2003; Fisk and Winey, 2001; Kasbek
et al., 2007). First, Mps1 is localized not only to SPBs in yeast
but also to centrosomes in mammalian cells (Dou et al., 2003;
Fisk et al., 2003; Fisk and Winey, 2001; Tyler et al., 2009). Over-
expression of mammalian Mps1 leads to centrosome overdupli-
cation, whereas overexpression of kinase-inactive Mps1 blocks
centrosome duplication and maintenance (Dou et al., 2004;
Fisk et al., 2003; Fisk and Winey, 2001; Kasbek et al., 2007).
The centrosomal levels of Mps1 are exquisitely controlled by
the Cdk2 phosphorylation of Mps1, which is required to prevent
the proteasome-mediated degradation of Mps1 and is sufficient
to promote centrosome duplication (Fisk and Winey, 2001; Kas-
bek et al., 2007). Collectively, these studies suggest the exis-
tence of a regulatory system that tightly controls the centrosomal
levels of Mps1 to prevent centrosome overduplication in human
cells.
Cyclin-dependent kinase inhibitor 3 (Cdkn3) is a dual-speci-
ficity phosphatase that dephosphorylates monomeric Cdk2 at
Thr160 (Gyuris et al., 1993; Hannon et al., 1994). As the phos-
phorylation of Thr160 is necessary for full Cdk2 activity and
cell-cycle progression, overexpressed Cdkn3 delays the G1-S
phase transition (Poon and Hunter, 1995). Notably, Cdkn3 has
been found to be aberrantly expressed in many human carci-
nomas, and variant Cdkn3 mRNA transcripts that code for
proteins lacking Cdk2-dephosphorylating activity have been
identified (Yeh et al., 2000; Yu et al., 2007), suggesting a potential
role for Cdnk3 in suppressing tumor progression. Recently,
Cdkn3 was also found to be involved in SAC signaling and
centrosome maintenance (Nalepa et al., 2013), although it is un-
clear whether the increased numbers of centrosomes in Cdkn3-
depleted cells are a consequence of failed mitosis because of
defects in SAC signaling or centrosome overduplication.orts 13, 1569–1577, November 24, 2015 ª2015 The Authors 1569
Figure 1. Cdkn3 Is a Direct Binding Partner
of Mps1
(A) Isolation of Cdkn3 as an interacting partner
of Mps1. Yeast two-hybrid assay is shown. The
interaction between Cdkn3 and Mps1 was evalu-
ated by colony growth (top) and X-gal staining
(bottom) assays in quadruple-dropout media
(QDO) (SD/-Leu/-Trp/-His/-Ura). Each yeast col-
ony grown under permissive conditions on dou-
ble-dropout plates (DDO) (SD/-Leu/-Trp) was
streaked on the QDO plates. EV, empty vector.
(B) 293T cells transiently expressing Myc-Mps1
and GFP-Cdkn3 were subjected to immunopre-
cipitation (IP) with antibodies against Myc-epitope
and immunoblot (IB) analysis. WCL, whole-cell
lysates.
(C) Asynchronously growing MDA-MB-231 cells
were subjected to immunoprecipitation analysis
with antibodies against Cdkn3.
(D) Structural motifs of Mps1 with a summary of
the Cdkn3:Mps1 interactions are shown.
(D and E) Yeast two-hybrid assay. The interaction
between Cdkn3 and Mps1 was evaluated by
colony growth and b-galactosidase assay. Each
yeast colony grown on the DDO plates was
streaked on the QDO plates.
(F) Alignment of the putative Cdkn3-binding
sequence of Mps1 between different species with
the changes to generate point mutants of Mps1
defective in binding Cdkn3 that were used for
yeast two-hybrid assay.
(G) Each yeast colony grown on the QDO plates
was re-streaked on the QDO plates for colony
growth and b-galactosidase assay (top panels).
The expression levels of the indicatedMyc-tagged
Mps1 baits in yeast grown in DDO were deter-
mined by immunoblot analysis (bottom panels).
(H) Lysates from 293T cells transiently expressing
Myc-Mps1 and GFP-Cdkn3 were subjected to
immunoprecipitation analysis with antibody against
the Myc-epitope.Here, we show that Cdkn3 is essential for preventing Mps1-
mediated centrosome overduplication in human cells. We have
isolated Cdkn3 as a direct binding partner of Mps1 using yeast
two-hybrid screening and identified critical amino acid residues
inMps1 that are responsible for the Cdkn3:Mps1 interaction. Us-
ing siRNA-mediated depletion-reconstitution, we demonstrate
that the Cdkn3:Mps1 interaction is required for maintaining the
proper number of centrosomes, as failure to recruit Cdkn3 to
Mps1 at centrosomes contributes to centrosome overduplica-
tion. Importantly, we show that Mps1 recruits Cdkn3 to cen-
trosomes and forms a regulatory system that controls its own
centrosomal levels in a proteasome-dependent manner. This
self-regulatory feedback loop tightly controls the centrosomal
levels of Mps1 to maintain the proper number of centrosomes.
RESULTS
Identification of Cdkn3 as a Binding Partner of Mps1
To better understand Mps1 function in mitotic progression
and centrosome maintenance, we searched for protein partners1570 Cell Reports 13, 1569–1577, November 24, 2015 ª2015 The Authat directly bind Mps1 using the yeast two-hybrid method with
full-length Mps1 as bait. Screening of a HeLa cDNA library iden-
tifiedmultiple colonies containing cDNA of full-length Cdkn3 (aas
1–212). The interaction betweenMps1 and Cdkn3 was verified in
a directed two hybrid for growth on medium lacking histidine as
well as b-galactosidase assay (Figure 1A). Consistent with this
finding, transiently expressed Myc-tagged Mps1 co-immuno-
precipitated with GFP-tagged Cdkn3 (Figure 1B). Furthermore,
endogenous Mps1 also co-immunoprecipitated with endoge-
nous Cdkn3 (Figure 1C), indicating that Cdkn3 is a binding part-
ner of Mps1. Using the two-hybrid interaction, we performed a
fine mapping of the Cdkn3-binding site on Mps1. Notably, the
Mps1 domain (aas 400–525) containing a Cdk2 phosphoryla-
tion-dependent Mps1 degradation signal (MDS), which controls
the stability of Mps1 at centrosomes (Kasbek et al., 2007), was
both necessary and sufficient for Cdkn3 binding (Figures 1D
and 1E). Further deletion analysis of Mps1 revealed that a
small motif of Mps1 (aas 420–475) was sufficient for the interac-
tion with Cdkn3 (Figures 1D and 1E), suggesting that this small
amino acid stretch is essential for Cdkn3 binding. Next, basedthors
on sequence conservation among species (Figure 1F), a series
of alanine-scanning point mutations were introduced in this
minimal motif (aas 420–475). Mps1 point mutants in which
residues 456–460 or 461–465 (Figure 1F) were replaced with
alanine (SNTLD/AAAAA, 456(5A) or DYMSC/AAAAA, 461(5A)),
but not surrounding amino acid residues, failed to bind Cdkn3
(Figure 1G, top panels). Similarly, full-length Mps1 mutants con-
taining these alanine substitutions also failed to bind Cdkn3
(Figure 1G, top panels), although these mutants were properly
expressed in yeast (Figure 1G, bottom panel). Furthermore,
whenMyc-Mps1 andGFP-Cdkn3were transiently co-expressed
in 293T cells and subjected to immunoprecipitation analysis us-
ing anti-Myc antibodies, wild-type Myc-Mps1 (Mps1WT), but not
461(5A) mutant (Mps1461(5A)), was co-immunoprecipitated
together with GFP-Cdkn3 (Figure 1H), suggesting that amino
acid residues 456–465 in Mps1 are essential for binding Cdkn3.
Cdkn3 Is Required forMaintaining the Proper Number of
Centrosomes, but Not SAC Signaling
Cdkn3 is a dual-specificity phosphatase that functions as an
interphase Cdk inhibitor (Gyuris et al., 1993; Hannon et al.,
1994). Interestingly, recent evidence indicates the requirement
for Cdkn3 in promoting the SAC and centrosome maintenance,
as siRNA-mediated depletion of Cdkn3 causes SAC silencing
and supernumerary centrosome formation in multinucleated
HeLa cells (Nalepa et al., 2013), which could be attributed to
the recognized function of Mps1. Thus, we speculated that
Mps1 and Cdkn3 may function as a complex in promoting the
SAC. To test this, we first determined the mRNA abundance of
Cdkn3 in various cell lines by real-time PCR (qPCR) analysis
(Figure S1A). Cdkn3 was highly expressed in asynchronously
growing MDA-MB-231, DU145, and AGS cells. MDA-MB-231
cells were transfected with four different siRNAs to deplete
endogenous Cdkn3 (Figure S1B). As determined by qPCR
analysis and immunoblot analysis (Figures S1B and S1C),
each siRNA transfection efficiently caused a similar decrease
in Cdkn3 mRNA and protein levels. Notably, when challenged
with the microtubule depolymerizer nocodazole for 20 hr,
MDA-MB-231 cells depleted of Cdkn3 were arrested in mitosis
with a similar mitotic index to that seen in MDA-MB-231 cells
transfected with non-silencing control siRNA (Figure S1D). Un-
der this condition, MDA-MB-231 cells depleted of an essential
SAC component, Mps1 or Mad2, markedly decreased the
mitotic index, as expected (Figure S1D). Similarly, DU-145 and
HeLa cells depleted of Cdkn3 showed an increasedmitotic index
and mitotic rounded-up cells comparable to controls after treat-
ment with nocodazole (Figures S1D and S1E). Together, these
results suggest that Cdkn3 is unlikely to be required to promote
SAC signaling, although we cannot rule out the possibility that
even a small amount of Cdkn3 might be sufficient for SAC.
In contrast, knockdown of Cdkn3 significantly increased the
number of cells with greater than or equal to three centrosomes
in theMDA-MD-231, DU-145, and HeLa cell lines, as determined
by immunofluorescence analysis using anti-g-tubulin staining
(Figure 2A). Notably, the centrosomes in these Cdkn3-depleted
cells were present in close proximity without any measurable in-
duction of multinucleated cells (Figures S2A and S2B) similar to
that seen in Plk4-overexpressed cells (Figures S2C and S2D; Ha-Cell Repbedanck et al., 2005), suggesting a potential role for Cdkn3 in
maintaining the proper number of centrosomes rather than in
the SAC. To further rule out contributions from errors in mitosis
and/or cytokinesis, Cdkn3-depleted HeLa and DU-145 cells
were arrested in S phase using hydroxyurea (HU), which permits
ongoing centrosome duplication in the absence of DNA replica-
tion or cytokinesis (Meraldi et al., 1999). Importantly, Cdkn3
depletion caused a significant increase in the number of cells
with supernumerary centrosomes and centrioles, as determined
by anti-g-tubulin and anti-CP110 (a centriole marker) staining
(Figures 2B and 2C). The effect of Cdkn3 siRNA on centrosome
overduplication was specific to the depletion of Cdkn3 because
transiently expressedGFP-Cdkn3 significantly reduced the num-
ber of cells with greater than or equal to three centrosomes
(Figure 2D). Furthermore, as determined by immunofluorescence
analysis using antibodies against Cdkn3 and the centrosome
marker g-tubulin, endogenous Cdkn3 localized at centrosomes,
whereas siRNA-mediated depletion of Cdkn3 abolished the
centrosome localization of Cdkn3 and increased centrosome
number (Figure 2E). Similarly, transiently expressed mCherry-
tagged Cdkn3 also localized to centrosomes (Figure 2F),
excluding the possibility of non-specific immunofluorescence
staining. Together, our data suggest that Cdkn3 is a centrosomal
protein that plays an essential role in maintaining the proper
number of centrosomes. Therefore, we hypothesized that the
Cdkn3:Mps1 interaction may occur at centrosomes and play a
key role in maintaining the proper number of centrosomes.
The Cdkn3:Mps1 Interaction Is Required for Recruiting
Cdkn3 to Centrosomes
Centrosome reduplication requires Cdk2/cyclin A (Balczon,
2001; Meraldi et al., 1999). As Cdkn3 directly binds and inhibits
Cdk2 activity (Gyuris et al., 1993; Hannon et al., 1994), it was
difficult to evaluate the importance of the Cdkn3:Mps1 inter-
action in centrosome maintenance by siRNA-mediated deple-
tion of Cdkn3 alone. Therefore, using the Cdkn3-binding-
deficient Mps1 point mutants, we determined the importance
of the Cdkn3:Mps1 interaction in the centrosomal localization
of Cdkn3. To address this, endogenous Mps1 in MDA-MB-231
cells was depleted and replaced with an exclusively centroso-
mal-localized version of Mps1 by inserting the PACT domain at
the C terminus of GFP-Mps1 (GFP-Mps1-PACT) (Kasbek et al.,
2007). These cells were subsequently treated with the protea-
some inhibitor MG132 to exclude the potential complication
of Mps1 degradation at the centrosome (Kasbek et al., 2007).
The centrosomal levels of endogenous Cdkn3 relative to the
centrosomal marker g-tubulin in cells expressing either wild-
type (GFP-Mps1WT-PACT) or mutant (GFP-Mps1461(5A)-PACT)
defective in Cdkn3 binding were quantified. As expected, GFP-
Mps1WT-PACT exclusively localized to centrosomes (Figure 3A).
Endogenous Cdkn3 also well co-localized with GFP-Mps1WT-
PACT at centrosomes (Figure 3A). Similar to GFP-Mps1WT-
PACT, GFP-Mps1461(5A)-PACT also exclusively localized at
centrosomes (Figure 3A). However, the centrosomal levels of
endogenous Cdkn3 were significantly lower than those in cells
expressing GFP-Mps1WT-PACT, although some residual centro-
somal localization of Cdkn3 was still detected (Figures 3A and
3B), which may possibly occur through its interaction with Cdk2orts 13, 1569–1577, November 24, 2015 ª2015 The Authors 1571
Figure 2. Cdkn3 Is Required for Maintaining
the Proper Number of Centrosomes
(A–C) Asynchronously growing cells from the
indicated lines were transfected with non-
silencing or siRNA against Cdkn3 two times with a
24-hr interval. At 48 hr after transfection, the cells
were subjected to immunofluorescence analysis
using antibodies against g-tubulin and DAPI. For
(B) and (C), the indicated cell lines were treated
with hydroxyurea (HU) for 48 hr before fixation.
Quantification results of the numbers of g-tubulin
or CP110-positive foci are shown (n > 40 cells
per condition from two independent experi-
ments; ±SD). (B) Representative image of DU-145
cells from (C) is shown.
(D) Quantification of the numbers of g-tubulin
foci in GFP-positive HeLa cells (n > 40 cells per
condition). The Cdkn3 siRNA was transfected as
above, except 10 ng of plasmid encoding GFP-
tagged Cdkn3 was included in the second trans-
fection.
(E) Cdkn3 localizes to centrosomes. DU-145 cells
were prepared as in (B) and subjected to immu-
nofluorescence analysis using antibodies against
Cdkn3 and g-tubulin.
(F) MDA-MB-231 cells transiently expressing
mCherry-Cdkn3 were subjected to immunofluo-
rescence analysis. Inset represents the boxed
area.
White bars represent 5 mm. See also Figures S1
and S2.or residual endogenous Mps1. Nevertheless, these results
suggest that the Cdkn3:Mps1 interaction promotes Cdkn3
recruitment to the centrosome.
Cdkn3 Destabilizes Mps1 at Centrosomes
Notably, siRNA-mediated depletion of Cdkn3 significantly
increased the centrosomal levels of endogenous Mps1 in MDA-
MB-231 cells, as determined by immunofluorescence analysis
(Figures 3C and 3D). The centrosomal levels of Mps1 are regu-
lated by proteasome-mediated degradation (Kasbek et al.,
2007). Indeed, MG132 treatment increased the centrosomal
levels of Mps1 in MDA-MB-231 cells (Figure 3D). In contrast,
the increased centrosomal levels of endogenous Mps1 in MDA-1572 Cell Reports 13, 1569–1577, November 24, 2015 ª2015 The AuthorsMB-231 cells depleted of Cdkn3 were
not significantly further augmented by
MG132 treatment (Figure 3D), which sug-
gests that Cdkn3 controls the centroso-
mal levels of Mps1. Conversely, enforcing
the centrosomal localization of Cdkn3 by
inserting a PACT domain (Gillingham and
Munro, 2000) at the C terminus of GFP-
tagged Cdkn3 (GFP-Cdkn3-PACT) signif-
icantly decreased the centrosomal levels
of endogenous Mps1 in both MDA-MB-
231 and HeLa cells (Figures 3E and 3F).
This decrease was due to the protea-
some-mediated degradation of Mps1
at centrosomes, as MG132 treatmentrestored the centrosomal levels of Mps1 in MDA-MB-231 cells
expressing GFP-Cdkn3-PACT (Figure 3E). Together, our data
suggest that Cdkn3 negatively controls the centrosomal levels
of Mps1 by either directly or indirectly promoting the protea-
some-mediated degradation of Mps1 at centrosomes.
The Cdkn3:Mps1 Interaction Is Required for
Destabilizing Mps1 at Centrosomes
The MDS motif within Mps1 (aa 420–507) is responsible for
destabilizing Mps1 at the centrosome, whereas Cdk2 phosphor-
ylation within this MDS motif, especially at Thr468 residue (Fig-
ure 1F), promotes the centrosomal stability of Mps1 (Kasbek
et al., 2007). Given that the MDS motif nearly overlaps with the
Figure 3. The Cdkn3:Mps1 Interaction Is
Required for Controlling the Centrosomal
Stability of Msp1
(A and B) MDA-MB-231 cells were transiently
transfected with an expression vector encoding
the indicated siRNA-resistant GFP-Mps1-PACT
together with siRNA against endogenousMps1. At
48 hr after transfection, cells were treated with
MG-132 (20 mM) for 4 hr and subjected to immu-
nofluorescence analysis using antibodies against
Cdkn3 and g-tubulin. Inset represents the boxed
area. (B) Quantification results of the centrosomal
levels of Cdkn3 relative to g-tubulin are shown
(n > 30 cells per condition; ±SD).
(C and D) MDA-MB-231 cells were transfected
with either control or Cdkn3 siRNAs for 48 hr and
subjected to immunofluorescence analysis using
antibodies against Mps1 and g-tubulin.
(E and F) MDA-MB-231 (E) or HeLa (F) cells were
transiently transfected with an expression vector
encoding GFP-PACT or GFP-Cdkn3-PACT. At
48 hr after transfection, cells were subjected
to immunofluorescence analysis using antibodies
against Mps1 and g-tubulin. (D–F) Quantifica-
tion results of the centrosomal levels of Mps1
relative to g-tubulin are shown (n > 20 cells per
condition; ±SD).
(G) MDA-MB-231 cells were transiently trans-
fected with expression vectors encoding GFP-
PACT or the indicated GFP-Mps1-PACT together
with mCherry or mCherry-Cdkn3. At 24 hr after
transfection, cells were subjected to immuno-
fluorescence analysis using antibodies against
g-tubulin to visualize centrosome.
(H) Quantification results of the centrosomal levels
of GFP relative to g-tubulin are shown (n > 30 cells
per condition; ±SD).
Student’s t test was performed to determine the
statistical significance (**p < 0.01; ***p < 0.001;
N.S., not significant). Where indicated, cells were
treated with MG-132 (20 mM) for 4 hr before fixa-
tion. Inset represents the boxed area. White bars
represent 5 mm. See also Figure S3.Mps1 binding site of Cdkn3 (Figures 1D–1G), wewished to deter-
minewhether theCdkn3:Mps1 interaction controls the stability of
Mps1 at the centrosome using the point mutants of Mps1 defec-
tive in binding Cdkn3 (Figures 1G and 1H). To address this,
GFP-Mps1-PACT or GFP-PACT was transiently expressed in
MDA-MB-231 cells together with either mCherry-tagged Cdkn3
or mCherry alone. The centrosomal levels of GFP-Mps1-PACT
or GFP-PACT relative to the centrosomal marker g-tubulin
were then quantified. As expected, GFP-PACT and GFP-Mps1-
PACT exclusively localized to centrosomes in cells co-express-Cell Reports 13, 1569–1577, Noing mCherry (Figure 3G). Overexpressed
mCherry-Cdkn3 was also found in cen-
trosomes, but the centrosomal levels of
GFP-PACT relative to g-tubulin were
not changed (Figures 3Ga, 3Gb, and
3H). In contrast, the relative centrosomal
levels of GFP-Mps1WT-PACT were mark-
edly decreased in cells co-expressingmCherry-Cdkn3 compared with mCherry (Figures 3Gc, 3Gd,
and 3H). These results are consistent with the decrease in the
centrosomal levels of endogenous Mps1 caused by targeting
Cdkn3 to centrosomes (Figures 3E and 3F). Importantly, the rela-
tive centrosomal levels of the GFP-Mps1461(5A)-PACT mutant
defective in binding Cdkn3 were not measurably affected
by co-expressing mCherry-Cdkn3 (Figure 3H), indicating the
requirement of the Cdkn3:Mps1 interaction to inhibit the
centrosomal stability of Mps1. Furthermore, the Cdkn3:Mps1
interaction may destabilize Mps1 at centrosomes by alteringvember 24, 2015 ª2015 The Authors 1573
Figure 4. The Cdkn3:Mps1 Interaction Is
Required for Maintaining the Proper Num-
ber of Centrosomes
(A–E) The indicated cell lines were transiently
transfected with an expression vector encoding
GFP-PACT fused with either wild-type or mutant
Mps1 defective in binding Cdkn3. At 48 hr after
transfection, cells were subjected to immuno-
fluorescence analysis using antibodies against
g-tubulin. Inset represents the boxed area, and the
white bar represents 5 mm (A). (B–E) Quantification
of centrosome number is shown (n > 30 cells
expressing GFP-Mps1-PACT per condition; ±SD).
For (D) and (E), cells were further treated with HU
for 24 hr before fixation. Student’s t test was per-
formed to determine the statistical significance
(*p < 0.05; **p < 0.01; ***p < 0.001).
(F and G) Using the indicated siRNAs (100 nM to-
tal), asynchronously growing DU-145 or HeLa cells
were transfected twice with a 24-hr interval. After
the second transfection, cells were treated with
HU for 48 hr and subjected to immunofluores-
cence analysis using antibodies against g-tubulin
and DAPI (n > 40 cells per condition; ±SD).
(H) Schematic model. Cdk2 phosphorylation of
Mps1 (Mps1-p) promotes the stabilization of
Mps1-p at the centrosome. In turn, Mps1-p re-
cruits Cdkn3 to the centrosome, which promotes
the proteasome-mediated degradation of Mps1,
possibly via the dephosphorylation of Mps1-p in
a direct or indirect manner. This self-regulated
feedback loop at centrosomes tightly controls the
centrosomal levels of Mps1 for proper centro-
some duplication (i). Conversely, in the absence of
Cdkn3, Mps1-p accumulates at centrosomes and
leads to centrosome overduplication (ii).
See also Figure S4.the Cdk2-dependent phosphorylation of the MDS motif in
Mps1 because the relative centrosomal levels of the GFP-
Mps1T453E/T468E-PACT mutant that mimics Cdk2 phosphoryla-
tion (Kasbek et al., 2007) were not significantly changed by
co-expressing mCherry-Cdkn3 (Figures 3H and S3A). Of note,
the difference in the centrosomal levels of Mps1 was not due
to the transfection efficiency because each of the Mps1 con-
structs was comparably expressed, as determined by immuno-
blot analysis (Figure S3B). Furthermore, this inability of Cdkn3
to destabilize Mps1T453E/T468E at centrosomes was not due to
defects in the Cdkn3:Mps1 interaction, as determined using
quantitative b-galactosidase as well as immunoprecipitation
analysis, whereas non-phosphorylatable Mps1T453A/T468A was
less able to bind Cdkn3 than Mps1T453E/T468E (Figures S3C and
S3D). Moreover, preventing Cdk2 phosphorylation was sufficient
to promote Mps1 degradation at centrosomes in the absence of
Cdkn3 binding because the relative centrosomal levels of the
compound mutant defective for both Cdkn3 binding and Cdk2
phosphorylation (Mps1461(5A)-T453A/T468A) were markedly lower
than Mps1461(5A) but were restored by MG132 treatment (Fig-
ure S3E). Collectively, our data suggest that the Cdkn3:Mps1
interaction is required to destabilize Mps1 at centrosomes and
that Cdk2 phosphorylation of Mps1 may create a self-regulated
feedback loop that controls the centrosomal levels of phosphor-
ylated Mps1 by recruiting Cdkn3 to centrosomes.1574 Cell Reports 13, 1569–1577, November 24, 2015 ª2015 The AuTheCdkn3:Mps1 Interaction Is Required forMaintaining
the Proper Number of Centrosomes
Using the Mps1 point mutants defective in binding Cdkn3, we
further determined the importance of the Cdkn3:Mps1 interac-
tion in the maintenance of centrosome number in MDA-MD-
231 and DU-145 cells. As shown previously, overexpressed
GFP-Mps1WT-PACT marginally but measurably increased the
number of cells possessing greater than or equal to three
centrosomes compared to the negative control, GFP-PACT
alone (Figures 4A–4C; Kasbek et al., 2007). Importantly, the
Cdkn3:Mps1 interaction was required for the maintenance of
centrosome numbers because Mps1 point mutants defective
in binding Cdkn3 (GFP-Mps1461(5A)-PACT) further increased
the number of cells possessing greater than or equal to three
centrosomes (Figures 4B and 4C). To further confirm this,
GFP-Mps1-PACT was transiently expressed in DU-145 and
HeLa cells, which were subsequently arrested in S phase using
HU. We noticed that overexpressed GFP-Mps1WT-PACT signif-
icantly increased the number of cells possessing greater than or
equal to three centrosomes (Figures 4D and 4E). Importantly,
under this condition, overexpressed GFP-Mps1461(5A)-PACT
further increased the number of cells possessing greater than
or equal to three centrosomes (Figures 4D and 4E), suggesting
that the Cdkn3:Mps1 interaction is required for maintaining the
proper number of centrosomes.thors
Finally, we determined whether stabilized Mps1 at centro-
somes in cells depleted of Cdkn3 is required for centrosome
overduplication. To test this, endogenous Mps1 and Cdkn3
were simultaneously depleted in either DU-145 or HeLa cells
using individual siRNAs. Then, the cells were subsequently
arrested in S phase with HU for 48 hr. Whereas Cdkn3 depletion
caused a significant increase in the number of cells with supernu-
merary centrosomes, simultaneous deletion of Mps1 and Cdkn3
significantly suppressed the number of cells with supernumerary
centrosomes in both cell lines (Figures 4F and 4G). Of note,
this suppression of centrosome overduplication was not simply
due to an inefficient depletion of Cdkn3, as determined by
qPCR analysis (Figure S4A). Furthermore, transient expression
of GFP-tagged wild-type Mps1, but not a kinase-dead mutant,
significantly increased the number of cells possessing greater
than or equal to three centrosomes only in the absence of
Cdkn3 (Figure S4B), indicating the role of Cdkn3 in preventing
Mps1-induced centrosome overduplication. Taken together,
our results suggest that the Cdkn3:Mps1 interaction is required
for maintaining the proper number of centrosomes by regulating
the stability of Mps1 at centrosomes (Figure 4H).
DISCUSSION
Excess Mps1 levels at centrosomes or the expression of a non-
degradable form of Mps1 promotes centrosome overduplication
in mouse and human cell lines (Cui et al., 2010; Fisk and Winey,
2001; Kasbek et al., 2007), suggesting the existence of a regula-
tory system, whose identity has remained elusive, that tightly
controls the centrosomal levels of Mps1. Our current study
reveals that Cdkn3 plays a key role in controlling the centrosomal
stability of Mps1 and inmaintaining the proper number of centro-
somes based on the following results: (1) MDA-MB-231, DU-
145, and HeLa cells depleted of Cdkn3 exhibited centrosome
overduplication; (2) Cdkn3 depletion increased the centrosomal
levels of Mps1, whereas Cdkn3 overexpression decreased the
Mps1 levels in a proteasome-dependent manner; (3) the centro-
somal levels of Mps1 mutants defective in binding Cdkn3 were
unaffected by overexpression of Cdkn3; (4) these Mps1 mutants
caused centrosome overduplication; and (5) centrosome over-
duplication in cells depleted of Cdkn3 was suppressed by
simultaneously depleting Mps1. As the Cdkn3:Mps1 interac-
tion promotes Cdkn3 recruitment to centrosomes (Figures 3A
and 3B), our data suggest that the Cdkn3:Mps1 interaction at
centrosomes may create a situation where Mps1 is recognized
by the factors (Kasbek et al., 2010; Liu et al., 2013) that drives its
own degradation at centrosomes, creating a self-regulatory
feedback loop for proper centrosome duplication. Of note, it
has been suggested that the centrosomal levels of Mps1 are
exquisitely controlled by Cdk2 phosphorylation within the
MDS motif of Mps1, separately from other pools of Mps1
(Fisk and Winey, 2001; Kasbek et al., 2007). Similarly, either
knockdown or overexpression of Cdkn3 specifically affected
the centrosomal (Figure 3), but not the overall protein, levels
of Mps1 (Figures S1C and S3D). Furthermore, unlike wild-
type Mps1, the centrosomal levels of the phosphomimetic
Mps1T453E/T468E mutant were not affected by overexpression
of Cdkn3 (Figure 3H) despite its ability to bind Cdkn3 (FiguresCell RepS3C and S3D), suggesting that reversing the Cdk2 phosphory-
lation of Mps1 is a prerequisite step for Cdkn3 to promote Mps1
degradation at centrosomes. Future research efforts will be
required to test whether Cdkn3 is the phosphatase responsible
for directly reversing Cdk2 phosphorylation of the MDS motif in
Mps1 at centrosomes.
Cdkn3 binds both monomeric Cdk2 and cyclin-A-bound Cdk2
(Gyuris et al., 1993; Hannon et al., 1994; Poon and Hunter, 1995).
However, Cdkn3 only dephosphorylates Thr160 of monomeric
Cdk2 and does not block the kinase activity of cyclin-A-bound
Cdk2 (Poon and Hunter, 1995). Thus, upon degradation or disso-
ciation of cyclin A from Cdk2 at centrosomes, Cdkn3 may pro-
mote the dephosphorylation of Cdk2 as well as Mps1, and
Cdkn3 thereby simultaneously counters Cdk2 activity and pro-
longed Mps1 stabilization at centrosomes to prevent centro-
some overduplication. It is also possible that increasing Cdk2
activity at centrosomes in cells depleted of Cdkn3 may promote
Cdk2 phosphorylation of Mps1, which in turn further stabilizes
Mps1 at centrosomes, as seen inMBA-MD-231 cells (Figure 3C).
Nonetheless, an Mps1 mutant defective in binding Cdkn3 was
stabilized at centrosomes independent of Cdkn3 (Figure 3H)
and caused centrosome overduplication (Figure 4). These results
provide direct evidence that the Cdkn3:Mps1 interaction plays a
key role in maintaining the proper number of centrosomes by
suppressing the stability of Mps1 at centrosomes. Therefore,
whereas Cdk2 phosphorylation promotes the stabilization of
Mps1 at the centrosome, we propose that Cdk2 phosphoryla-
tion of Mps1 recruits Cdkn3 to the centrosome to promote the
proteasome-mediated degradation of Mps1 possibly through
dephosphorylating Mps1 in a direct or indirect manner. This
self-regulated feedback loop at centrosomes tightly controls
the centrosomal levels of Mps1, which prevents centrosome
overduplication (Figure 4H). Furthermore, by tying Cdkn3 to
Mps1, this system may be poised to extinguish the centrosomal
Mps1 signal as soon as Cdk2 activity drops (e.g., cyclin A degra-
dation), yet it can be re-engaged upon the reactivation of Cdk2
during S phase in the next cycle.
Cdkn3 has been found to be mutated or aberrantly expressed
in many human tumors, and variant Cdkn3 mRNA transcripts
that code for proteins lacking Cdk2-dephosphorylating activity
have been identified (Yeh et al., 2000; Yu et al., 2007). Thus, in
the future, it will be interesting to determine the extent to which
the dysregulated centrosomal levels and/or phosphatase activity
of Cdkn3 found in human tumors may affect the stability of
Mps1 at centrosomes that may contribute to centrosome over-
duplication, multipolar chromosome missegregation, and tumor
progression.
EXPERIMENTAL PROCEDURES
More detailed methods are described in the Supplemental Experimental
Procedures.
Yeast Two Hybridization
Full-length and fragments of humanMps1 (Kang et al., 2007) were PCR cloned
into the pGBKT7 vector (Clontech) as bait. The two-hybrid screen was
performed according to the manufacturer’s instructions using human
cDNA library in pGADT7 prey vectors (Matchmaker Gold Yeast Two-Hybrid
System; Clontech), and the interaction was evaluated by colony growth onorts 13, 1569–1577, November 24, 2015 ª2015 The Authors 1575
quadruple-dropout plates lacking Trp, Leu, His, and Ura (QDO), as well as via
b-galactosidase assay for validation.
Immunoblotting and Immunoprecipitation Analysis
Cells were lysed with either passive lysis buffer (Roche) or 1% NP-40 lysis
buffer (25 mM Tris-HCl [pH 7.4] and 150 mM NaCl) supplemented with
completemini (Roche) and phosphatase inhibitor cocktails (Sigma). For immu-
noprecipitation analysis, total cell lysates were incubated with 1 mg of anti-Myc
antibody (Sc-40; Santa Cruz Biotechnology) at 4C overnight. Protein A/G plus
agarose beads (Santa Cruz) were added and incubated at 4C for 1 hr. After
incubation, the beads were washed three times with 1% NP-40 lysis buffer
and subjected to immunoblot analysis.
Microscopy Analysis and Quantification
Images were acquired at RT with 3D-SIM using a Super Resolution Micro-
scope (Nikon) equipped with an iXon EM+ 885 EMCCD camera (Andor)
mounted on aNikon Eclipse Ti-E invertedmicroscopewith aCFI Apo TIRF (100
3/1.40 oil) objective and processed with the NIS-Elements AR software.
Centrosome numbers were quantified using 3D projection of the images in
NIS-Elements AR software followed by manual counting of centrosomes
in individual cells. For centrosomal fluorescence intensity measurements, a
background correction method was used.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.10.039.
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